Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Chembio Diagnostics Gets Brazilian Regulatory Approval for POC Multiplex Flavivirus Test

Chembio Diagnostics Gets Brazilian Regulatory Approval for POC Multiplex Flavivirus Test

Apr 09, 2019
|
staff reporter

NEW YORK (360Dx) – Chembio Diagnostics said today that it has received Brazilian health agency approval for its DPP Zika/Dengue/Chikungunya point-of-care system in collaboration with Bio-Manguinhos/Fiocruz, a Brazilian government agency and supplier of diagnostic products to the country's Ministry of Health.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Regulatory News & FDA Approvals

  1. Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

  2. Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test

  3. Snibe Diagnostic Obtains CE Mark for HIV Chemiluminescence Immunoassay

  4. FDA Grants EUAs for SARS-CoV-2 Tests From Clinical Enterprise, Qorvo Biotechnologies

  5. Lucira Health Nabs OTC EUA for SARS-CoV-2 Test, Expects Q1 Revenues of up to $4.5M

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.